Home » Research Summaries » Search Results

Archives: Research Summaries

Analysis of Pregnancy-Related Attacks in Neuromyelitis Optica Spectrum Disorder. A Systematic Review and Meta-Analysis

Journal: JAMA Network Open; August 4, 2022

Author(s): Liang Wang, Manqiqige Su, Zhirui Zhou, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Wenjuan Huang, Xuechun Chang, Chuanzhen Lu, Jian Yu, Min Wang, Jiahong Lu, Chongbo Zhao, Tiansong Zhang, Chao Quan

A large-scale review study of pregnancy-related attacks in NMOSD patients

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study

Journal: Neurology; July 30, 2025

Author(s): Jeffrey L Bennett, Kazuo Fujihara, Albert Saiz, Anthony L Traboulsee, Benjamin M Greenberg, Brian G Weinshenker, Francesco Patti, Ingo Kleiter, Jacqueline Palace, Jerome De Seze, Rachael Evans, Kathleen Blondeau, Gaëlle Klingelschmitt, Ivana Vodopivec, Masouda Rahim, Takashi Yamamura

How safe and effective is satralizumab over the long term in people with NMOSD?

Neuropsychologic Impact of MOGAD: A Patient Reported Outcomes Study

Journal: Neurology; October 8, 2024

Author(s): Bruna Leles Vieira de Souza, Yihan Zhang, Rebecca Salky, Monique Anderson, Takahisa Mikami, Rebecca Gillani, Mattia Wruble, Gabriela Romanow, Anastasia Vishnevetsky, and Giovanna Manzano

How do MOGAD patients report their own quality of life?

Performance of the 2023 diagnostic criteria for MOGAD: real-world application in a Chinese multicenter cohort of pediatric and adult patients

Journal: BMC Medicine; January 23, 2025

Author(s): Meng-Ting Cai, Yi Hua, Qi-Lun Lai, Sheng-Yao Su, Chun-Hong Shen, Song Qiao, Yong-Feng Xu, Zhe-Feng Yuan, Yin-Xi Zhang

Evaluating the 2023 diagnostic criteria for MOGAD in children and adults in China

The real-world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody-associated disease criteria in a Latin American cohort

Journal: European Journal of Neurology; September 17, 2024

Author(s): Edgar Carnero Contentti, Claudia Pestchanker, Ethel Ciampi, Sheila Castro Suarez, Cesar Caparo Zamalloa, Vanesa Daccach Marques, Katharina Messias, José Ignacio Gortari, Verónica Tkachuk, Berenice Silva, Carolina Mainella, Saúl Reyes, Jaime Toro, Juan Rodriguez, Edgar Correa-Diaz, Juan I. Rojas, Friedemann Paul

Evaluating the 2023 diagnostic criteria for MOGAD in real-world settings in Latin America

Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Journal: JAMA Neurology; September 3, 2024

Author(s): Young Nam Kwon, Boram Kim, Jun-Soon Kim, Kyung Seok Park, Da-Young Seo, Hyunjin Kim, Eun-Jae Lee, Young-Min Lim, Hyunjin Ju, Yeon Hak Chung, Ju-Hong Min, Tai-Seung Nam, Sooyoung Kim, Eunhee Sohn, Kyong Jin Shin, Jin Myoung Seok, Sunyoung Kim, Jong Seok Bae, Sukyoon Lee, Seong-il Oh, Yu Jin Jung, Jinseok Park, Seung Hyun Kim, Ki Hoon Kim, Ho Jin Kim, Jae Ho Jung, Seong-Joon Kim, Seung Woo Kim, Myoung-jin Jang, Jung-Joon Sung, Patrick Waters, Ha Young Shin, Sung-Min Kim

Does time taken to treat the first MOGAD attack affect the disease course? A study from South Korea

MOGAD treatment outcomes and relapse characteristics: Real-world experience from a Low-Middle income country

Journal: Multiple Sclerosis and Related Disorders; August 1, 2025

Author(s): Kshiteeja Jain, Kamakshi Dhamija, Vikram V Holla, K Thennarasu, Maya Bhat, Anita Mahadevan, M Netravathi

How MOGAD patients respond to azathioprine, mycophenolate mofetil, or rituximab: A study from India

Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Qualitative Patient and Clinician Interviews Informing the Development of a Conceptual Model

Journal: Neurology and Therapy; June 12, 2025

Author(s): Jeffrey L. Bennett, Asha Paireddy, Charlotte Cox, Megan Mayhew, Julia Stein, Teresa Gasalla, Béatrice Tugaut

What is life like for people with MOGAD? A visual model informed by patient and clinician interviews

Spinal movement disorders in NMOSD, MOGAD, and idiopathic transverse myelitis: a prospective observational study

Journal: Journal of Neurology; July 8, 2024

Author(s): Hesham Abboud, Rongyi Sun, Nikhil Modak, Mohamed Elkasaby, Alexander Wang & Michael Levy

How common are movement disorders such as spasms, muscle contractions, and tremors in neuroimmune diseases?

Cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: A narrative review

Journal: Multiple Sclerosis and Related Disorders; May 1, 2024

Author(s): Christina Kazzi, Rubina Alpitsis Terence J. O'Brien, Charles B. Malpas, Mastura Monif

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.